BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26394849)

  • 1. Use of Disinfection Cap to Reduce Central-Line-Associated Bloodstream Infection and Blood Culture Contamination Among Hematology-Oncology Patients.
    Kamboj M; Blair R; Bell N; Son C; Huang YT; Dowling M; Lipitz-Snyderman A; Eagan J; Sepkowitz K
    Infect Control Hosp Epidemiol; 2015 Dec; 36(12):1401-8. PubMed ID: 26394849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of intensified prevention measures on rates of hospital-acquired bloodstream infection in medical-surgical intensive care units, Israel, 2011 to 2019.
    Ben-David D; Vaturi A; Wulffhart L; Temkin E; Solter E; Carmeli Y; Schwaber MJ; ;
    Euro Surveill; 2023 Jun; 28(25):. PubMed ID: 37347415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation and long-term efficacy of a multifaceted intervention to reduce central line-associated bloodstream infections in intensive care units of a low-middle-income country.
    Latif A; Ali W; Haleem S; Mahmood F; Munir T; Virani N; Khan H; Qadir M; Roshan R; Hooda K; Khan NM; Zafar A; Pronovost P
    Am J Infect Control; 2024 Jul; 52(7):819-826. PubMed ID: 38336128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methods.
    Choi SW; Chang L; Hanauer DA; Shaffer-Hartman J; Teitelbaum D; Lewis I; Blackwood A; Akcasu N; Steel J; Christensen J; Niedner MF
    Pediatr Blood Cancer; 2013 Feb; 60(2):262-9. PubMed ID: 22522576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disinfection of vascular catheter connectors that are protected by antiseptic caps is unnecessary.
    Fillman KM; Ryder JH; Brailita DM; Rupp ME; Cavalieri RJ; Fey PD; Lyden ER; Hankins RJ
    Infect Control Hosp Epidemiol; 2024 Jan; 45(1):35-39. PubMed ID: 37466074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital-acquired bloodstream infections in patients with cancer: current knowledge and future directions.
    MacPhail A; Dendle C; Slavin M; McQuilten Z
    J Hosp Infect; 2024 Jun; 148():39-50. PubMed ID: 38490489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiseptic barrier cap effective in reducing central line-associated bloodstream infections: A systematic review and meta-analysis.
    Voor In 't Holt AF; Helder OK; Vos MC; Schafthuizen L; Sülz S; van den Hoogen A; Ista E
    Int J Nurs Stud; 2017 Apr; 69():34-40. PubMed ID: 28130997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Port protectors in clinical practice: an audit.
    Cameron-Watson C
    Br J Nurs; 2016 Apr 28-May 11; 25(8):S25-31. PubMed ID: 27126760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central Line Associated Blood Stream Infections in Pediatric Hematology/Oncology Patients With Different Types of Central Lines.
    Hord JD; Lawlor J; Werner E; Billett AL; Bundy DG; Winkle C; Gaur AH;
    Pediatr Blood Cancer; 2016 Sep; 63(9):1603-7. PubMed ID: 27198806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Implementation Science for a Sustained Reduction of Central-Line-Associated Bloodstream Infections in a High-Volume, Regional Burn Unit.
    Sood G; Caffrey J; Krout K; Khouri-Stevens Z; Gerold K; Riedel S; McIntyre J; Maragakis LL; Blanding R; Zenilman J; Bennett R; Pronovost P
    Infect Control Hosp Epidemiol; 2017 Nov; 38(11):1306-1311. PubMed ID: 28899444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol Caps or Alcohol Swabs With and Without Chlorhexidine: An In Vitro Study of 648 Episodes of Intravenous Device Needleless Connector Decontamination.
    Flynn JM; Rickard CM; Keogh S; Zhang L
    Infect Control Hosp Epidemiol; 2017 May; 38(5):617-619. PubMed ID: 28137322
    [No Abstract]   [Full Text] [Related]  

  • 12. A Central Line Care Maintenance Bundle for the Prevention of Central Line-Associated Bloodstream Infection in Non-Intensive Care Unit Settings.
    O'Neil C; Ball K; Wood H; McMullen K; Kremer P; Jafarzadeh SR; Fraser V; Warren D
    Infect Control Hosp Epidemiol; 2016 Jun; 37(6):692-8. PubMed ID: 26999746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curos™ Disinfection Caps for the Prevention of Infection When Using Needleless Connectors: A NICE Medical Technologies Guidance.
    O'Connell S; Dale M; Morgan H; Carter K; Carolan-Rees G
    Appl Health Econ Health Policy; 2021 Mar; 19(2):145-153. PubMed ID: 32754850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efforts of a Unit Practice Council to implement practice change utilizing alcohol impregnated port protectors in a burn ICU.
    Martino A; Thompson L; Mitchell C; Trichel R; Chappell W; Miller J; Allen D; Mann-Salinas E
    Burns; 2017 Aug; 43(5):956-964. PubMed ID: 28139260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Central Line-Associated Bloodstream Infections.
    Bell T; O'Grady NP
    Infect Dis Clin North Am; 2017 Sep; 31(3):551-559. PubMed ID: 28687213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily bathing with 4% chlorhexidine gluconate in intensive care settings: a randomized controlled trial.
    Pallotto C; Fiorio M; De Angelis V; Ripoli A; Franciosini E; Quondam Girolamo L; Volpi F; Iorio P; Francisci D; Tascini C; Baldelli F
    Clin Microbiol Infect; 2019 Jun; 25(6):705-710. PubMed ID: 30267930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of Central Line-Associated Bloodstream Infection Rates in Patients in the Adult Intensive Care Unit.
    Wallace MC; Macy DL
    J Infus Nurs; 2016; 39(1):47-55. PubMed ID: 26714119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of Central Venous Access Devices: A Systematic Review.
    Ullman AJ; Marsh N; Mihala G; Cooke M; Rickard CM
    Pediatrics; 2015 Nov; 136(5):e1331-44. PubMed ID: 26459655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.
    Gibson GE; Luchsinger JA; Cirio R; Chen H; Franchino-Elder J; Hirsch JA; Bettendorff L; Chen Z; Flowers SA; Gerber LM; Grandville T; Schupf N; Xu H; Stern Y; Habeck C; Jordan B; Fonzetti P
    J Alzheimers Dis; 2020; 78(3):989-1010. PubMed ID: 33074237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental finding of cornea verticillata or lamellar inclusions in kidney biopsy: measurement of lyso-Gb3 in plasma defines between Fabry disease and drug-induced phospholipidosis.
    Politei J; Frabasil J; Durand C; Di Pietrantonio S; Fernandez A; Albertón V; Velasquez Rivas D; Barriales-Villa R; Larrañaga-Moreira J; Schenone AB
    Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165985. PubMed ID: 33022387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.